CD97 Antikörper (Extracellular, N-Term)
Kurzübersicht für CD97 Antikörper (Extracellular, N-Term) (ABIN7884854)
Target
Alle CD97 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 499-512, Extracellular, N-Term
-
Verwendungszweck
- A Rabbit Polyclonal Antibody to CD97/ADGRE5
-
Homologie
- Human only
-
Aufreinigung
- Affinity purified on immobilized antigen.
-
Immunogen
- (C)KSDSDRGGHWATEG, corresponding to amino acid residues 499-512 of human CD97/ADGRE5
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:200
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: The optimal concentration should be determined by the user
IP: The optimal concentration should be determined by the user
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 0.2 mL double distilled water (DDW)
-
Konzentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Konservierungsmittel
- Without preservative
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- CD97
-
Andere Bezeichnung
- Adhesion G protein-coupled receptor E5
-
Hintergrund
-
Synonyms: Adhesion G protein-coupled receptor E5, Leukocyte antigen CD97, Seven-transmembrane heterodimeric receptor associated with inflammation
Description: CD97, encoded by the adhesion G protein-coupled receptor 5 (ADGRE5) gene, is a member of the epidermal growth factor (EGF) seven transmembrane receptor family, belonging to the adhesion family of G protein-coupled receptors (GPCRs)1. CD97 is widely expressed on the surface of lymphoid cells, macrophages, smooth muscle cells and several types of tumor cells and acts through binding of decay accelerating factor (CD55) and dermatan sulfate2.In the immune system, CD97 is known as a critical mediator of host defense. Upon lymphoid, myeloid cells and neutrophil activation, CD97 is upregulated to promote adhesion and migration to sites of inflammation3. Antibodies against CD97 have been demonstrated to diminish various inflammatory disorders by depleting granulocytes and the interaction between CD97 and its ligand CD55 regulates T-cell activation and increases proliferation and cytokine production4.Changes in the expression of CD97 have been described in auto-inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis. Outside the immune system, CD97 is likely involved in cell-cell interactions and ectopic CD97 expression leading to enhanced cell-cell aggregation5.
-
Gen-ID
- 976
-
UniProt
- P48960
Target
-